Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of the ERalpha germline PvuII marker in breast cancer risk.

Medical science monitor : international medical journal of experimental and clinical research - 1 Mar 2008

González-Mancha Rosario, Galán Jose Jorge, Crespo Carmen, Iglesias Pérez Luis, González-Perez Antonio, Morón Francisco Jesús, Moreno Nogueira José Andrés, Real Luis Miguel, Pascual Manuel Hidalgo, Ruiz Agustin, Royo Jose Luis

Abstract excerpt

BACKGROUND: Prolonged exposure to estrogens was found to be a risk factor for breast cancer. The molecular mechanism has been suggested to be the binding of estrogen receptors in mammary tissue, which promotes the proliferation of breast tissue. Different biomarkers mapping estrogen receptor alpha (ESR1) have been associated with breast cancer risk, although the size of the effect is not consistent among...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Case-Control Studies

Share to Estrogen Receptor alpha

Share to Genetic Predisposition to Disease

Share to Phenotype

Share to Polymorphism, Single Nucleotide

Source

Identifiers

PMID: 18301357

Genes

ESR1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of the ERalpha germline PvuII marker in breast cancer risk.PMID 18301357Read ↗

Association between ERα gene Pvu II polymorphism and breast cancer susceptibility: A meta-analysis.Semantic proximity Read ↗

The estrogen receptor alpha gene and breast cancer risk (The Netherlands).Semantic proximity Read ↗

Association of ESRα-Pvull and ESRα-Xbal Polymorphisms with Breast Cancer Susceptibility in an Iranian Population: A Hospital-Based Case-Control Study.Semantic proximity Read ↗

Estrogen receptor alpha polymorphisms and postmenopausal breast cancer risk.Semantic proximity Read ↗

Genetic polymorphims of estrogen receptor alpha -397 PvuII (T>C) and -351 XbaI (A>G) in a portuguese population: prevalence and relation with breast cancer susceptibility.Semantic proximity Read ↗

Estrogen receptor alpha (ERS1) SNPs c454-397T>C (PvuII) and c454-351A>G (XbaI) are risk biomarkers for breast cancer development.Semantic proximity Read ↗

Menopausal status modifies breast cancer risk associated with ESR1 PvuII and XbaI polymorphisms in Asian women: a HuGE review and meta-analysis.Semantic proximity Read ↗

Association between estrogen receptor alpha PvuII polymorphism and prostate cancer risk.Semantic proximity Read ↗

Association of ER-α gene PvuII polymorphism with ovarian cancer.Semantic proximity Read ↗

ESR1 PvuII polymorphism: from risk factor to prognostic and predictive factor of the success of primary systemic therapy in advanced breast cancer.Semantic proximity Read ↗

Analysis of the PvuII restriction fragment-length polymorphism and exon structure of the estrogen receptor gene in breast cancer and peripheral blood.Semantic proximity Read ↗

Estrogen receptor alpha gene polymorphisms and breast cancer risk: a case-control study with meta-analysis combined.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.